OVERVIEW

Epilepsy is a heterogeneous and lifelong neurological condition that requires a nuanced, multidisciplinary approach to diagnosis, treatment, and long-term management. Affecting patients across the lifespan—from neonates to older adults—epilepsy encompasses a broad spectrum of seizure types, etiologies, comorbidities, and therapeutic challenges. As advances in neuroscience, pharmacology, genetics, and digital health continue to reshape epilepsy care, clinicians must stay current with evolving evidence to deliver precise, patient-centered treatment.

The Comprehensive Epilepsy CME Bundle: Diagnosis, Treatment, Genetics & Advanced Therapies is designed to provide an integrated, end-to-end educational experience that reflects the modern landscape of epilepsy care. This curated package brings together 10 on-demand CME/CE activities that collectively address foundational principles, clinical decision-making, emerging technologies, and patients' lived experience with epilepsy. Rather than focusing on a single dimension of care, the bundle intentionally spans the full continuum—from disease mechanisms and antiseizure pharmacology to artificial intelligence, neuromodulation, predictive devices, and neonatal epilepsy management.

Clinicians will review evidence-based approaches to antiseizure medications and rescue therapies, including optimization strategies and considerations for drug-resistant epilepsy. The package also explores self-limited epilepsies, emphasizing appropriate diagnosis and avoidance of overtreatment. Advances in genetic and personalized medicine are examined to help learners understand how molecular diagnosis increasingly informs treatment selection and prognosis, particularly in pediatric and early-onset epilepsy.

In recognition of rapid technological innovation, several courses address artificial intelligence, seizure prediction, and neuromodulation, including deep brain stimulation and other device-based therapies. These sessions highlight how emerging tools are reshaping seizure monitoring, risk stratification, and long-term disease management. Importantly, the bundle also incorporates the patient perspective, reinforcing quality-of-life considerations, shared decision-making, and the psychosocial impact of epilepsy beyond seizure control alone.

Designed for neurologists, epilepsy specialists, advanced practice providers, nurses, and trainees, this comprehensive CME bundle supports both clinical refreshers and deeper learning. By completing the full package, participants will strengthen diagnostic accuracy, enhance therapeutic confidence, and gain a forward-looking understanding of where epilepsy care is headed—ultimately improving outcomes for patients across diverse clinical settings.

Educational Objectives

  • Explain the pathophysiologic diversity of epilepsy and its implications for diagnosis and management.
  • Apply evidence-based principles to antiseizure medications, rescue therapies, and device-based interventions.
  • Integrate advances in genetics, artificial intelligence, and predictive technologies into epilepsy care.
  • Recognize special epilepsy populations, including neonatal and self-limited epilepsies.
  • Incorporate patient-centered perspectives into long-term epilepsy management.

Courses Included in This Package

Course TitleCME CreditsCE Credits
Epilepsy as a Prototype System Disease / Neuroprotection 0.50 0.50
Antiseizure Medications and Rescue Treatments1.001.00
Self-Limited Epilepsies0.500.50
Patient Perspective on Epilepsy0.500.50
Antiseizure Drugs in Epilepsy and Other Neurological Diseases1.001.00
Artificial Intelligence in Epilepsy1.001.00
Personalized Medications and Genetic Treatments in Epilepsy1.001.00
Neuromodulation and Deep Brain Stimulation in Epilepsy & Parkinson’s Disease1.001.00
Predictive Devices in Epilepsy1.001.00
Neonatal Seizures and Treatments0.500.50


Who Should Do This Course Package?

  • Clinicians seeking a comprehensive epilepsy learning pathway.
  • Providers managing epilepsy across outpatient and inpatient settings.
  • Trainees preparing for neurology or epilepsy board examinations.
  • Advanced practice providers involved in long-term epilepsy care.
  • Healthcare professionals focused on improving seizure control and quality of life.

Did You Know?

  • Approximately one-third of people with epilepsy experience drug-resistant epilepsy, underscoring the need for advanced therapies such as neuromodulation and individualized treatment planning. [Perucca 2023, Lancet Neurology]
  • More than 50 million people worldwide live with epilepsy, making it one of the most common severe neurological disorders globally. [WHO Epilepsy Fact Sheet, updated 2024]
  • Genetic testing can directly influence epilepsy management, including diagnosis, prognosis, and treatment selection—particularly in early-onset and pediatric epilepsies. [McKnight 2022, JAMA Neurology; Knowles 2022, Epilepsy Behav]
  • Machine learning approaches for seizure detection and prediction are rapidly evolving, leveraging EEG and wearable biosignals to support monitoring and risk stratification. [Rasheed 2021, IEEE Rev Biomed Eng]
  • Quality of life is impacted by epilepsy well beyond seizure frequency, reinforcing the importance of patient-centered outcomes and psychosocial comorbidity management. [Strzelczyk 2023, Epilepsy & Behavior; Vonck 2023, Epilepsia]
Credits

Artificial Intelligence in Epilepsy

Physician Accreditation Statement
eMedEd is an approved provider of continuing medical education by the Accreditation Council for Continuing Medical Education (ACCME), Provider #0008305. This activity is approved for 1 AMA PRA Category 1 Credits.

Nursing Accreditation Statement
eMedEd is an approved provider of continuing nursing education by the California Board of Registered Nursing. Provider approved by California Board of Registered Nursing, Provider #17890, for 1 contact hour.

Release Date: December 1st, 2025
Expiration Date: November 30th, 2026

Predictive Devices in Epilepsy

Physician Accreditation Statement
eMedEd is an approved provider of continuing medical education by the Accreditation Council for Continuing Medical Education (ACCME), Provider #0008305. This activity is approved for 1 AMA PRA Category 1 Credits.

Nursing Accreditation Statement
eMedEd is an approved provider of continuing nursing education by the California Board of Registered Nursing. Provider approved by California Board of Registered Nursing, Provider #17890, for 1 contact hour.

Release Date: December 1st, 2025
Expiration Date: November 30th, 2026

Self-Limited Epilepsies

Physician Accreditation Statement
eMedEd is an approved provider of continuing medical education by the Accreditation Council for Continuing Medical Education (ACCME), Provider #0008305. This activity is approved for 0.5 AMA PRA Category 1 Credits.
 

 Nursing Accreditation Statement
eMedEd is an approved provider of continuing nursing education by the California Board of Registered Nursing. Provider approved by California Board of Registered Nursing, Provider #17890, for 0.5 contact hour.

Release Date: December 1st, 2025
Expiration Date: November 30th, 2026

Patient Perspective on Epilepsy

Physician Accreditation Statement
eMedEd is an approved provider of continuing medical education by the Accreditation Council for Continuing Medical Education (ACCME), Provider #0008305. This activity is approved for 0.5 AMA PRA Category 1 Credits.

Nursing Accreditation Statement
eMedEd is an approved provider of continuing nursing education by the California Board of Registered Nursing. Provider approved by California Board of Registered Nursing, Provider #17890, for 0.5 contact hour.

Release Date: December 1st, 2025
Expiration Date: November 30th, 2026

Personalized Medications and Genetic Treatments in Epilepsy

Physician Accreditation Statement
eMedEd is an approved provider of continuing medical education by the Accreditation Council for Continuing Medical Education (ACCME), Provider #0008305. This activity is approved for 1 AMA PRA Category 1 Credits.

Nursing Accreditation Statement
eMedEd is an approved provider of continuing nursing education by the California Board of Registered Nursing. Provider approved by California Board of Registered Nursing, Provider #17890, for 1 contact hour.

Release Date: December 1st, 2025
Expiration Date: November 30th, 2026

Neonatal Seizures and Treatments

Physician Accreditation Statement
eMedEd is an approved provider of continuing medical education by the Accreditation Council for Continuing Medical Education (ACCME), Provider #0008305. This activity is approved for 0.5 AMA PRA Category 1 Credits.

Nursing Accreditation Statement
eMedEd is an approved provider of continuing nursing education by the California Board of Registered Nursing. Provider approved by California Board of Registered Nursing, Provider #17890, for 0.5 contact hour.

Release Date: December 1st, 2025
Expiration Date: November 30th, 2026

Antiseizure Drugs in Epilepsy and Other Neurological Diseases

Physician Accreditation Statement
eMedEd is an approved provider of continuing medical education by the Accreditation Council for Continuing Medical Education (ACCME), Provider #0008305. This activity is approved for 1 AMA PRA Category 1 Credits.

Nursing Accreditation Statement
eMedEd is an approved provider of continuing nursing education by the California Board of Registered Nursing. Provider approved by California Board of Registered Nursing, Provider #17890, for 1 contact hour.

Release Date: December 1st, 2025
Expiration Date: November 30th, 2026

Epilepsy as a Prototype System Disease/Neuroprotection

Physician Accreditation Statement
eMedEd is an approved provider of continuing medical education by the Accreditation Council for Continuing Medical Education (ACCME), Provider #0008305. This activity is approved for 0.5 AMA PRA Category 1 Credits.

Nursing Accreditation Statement
eMedEd is an approved provider of continuing nursing education by the California Board of Registered Nursing. Provider approved by California Board of Registered Nursing, Provider #17890, for 0.5 contact hour.

Release Date: December 1st, 2025
Expiration Date: November 30th, 2026

Antiseizure Medications and Rescue Treatments

Physician Accreditation Statement
eMedEd is an approved provider of continuing medical education by the Accreditation Council for Continuing Medical Education (ACCME), Provider #0008305. This activity is approved for 1 AMA PRA Category 1 Credits.
 

 Nursing Accreditation Statement
eMedEd is an approved provider of continuing nursing education by the California Board of Registered Nursing. Provider approved by California Board of Registered Nursing, Provider #17890, for 1 contact hour.

Release Date: December 1st, 2025
Expiration Date: November 30th, 2026

Neuromodulation and Deep Brain Stimulation in Epilepsy and Parkinsons Disease

Physician Accreditation Statement
eMedEd is an approved provider of continuing medical education by the Accreditation Council for Continuing Medical Education (ACCME), Provider #0008305. This activity is approved for 1 AMA PRA Category 1 Credits.

Nursing Accreditation Statement
eMedEd is an approved provider of continuing nursing education by the California Board of Registered Nursing. Provider approved by California Board of Registered Nursing, Provider #17890, for 1 contact hour.

Release Date: December 1st, 2025
Expiration Date: November 30th, 2026

  • 8 AMA PRA Category 1 Credits™
  • 8 Contact Hours

    • TARGET AUDIENCE

    PhysicianNursingPhysician Assistant

    SPECIALITIES

    Neurocritical CareEpilepsyCritical Care MedicineInternal MedicineFamily MedicineGeriatricsPediatricsPsychiatryNeurologyEmergency MedicinePediatric Rehabilitation MedicineNeurosurgeryNeurocritical CareGeriatric MedicinePrimary CarePediatrics NeurologyNeonatal Intensive Care NursingDevelopmental Behavioral PediatricsNeonatal and PerinatologyClinical NeurophysiologyPsychiatry and NeurologyClinical PharmacologyGeneticsCommunity NursingPediatric NursingGeneral PracticePain ManagementPhysical Medicine and RehabilitationNeurophysiologyClinical Informatics

    CANCELLATION & REFUND POLICY

    Refunds are subject to the following terms:

    • Eligibility: You may request a refund within 7 days of order confirmation only if none of the courses have been started (i.e., no course progress or completion has occurred).
    • Deductions: Refunds will be processed after deducting applicable online transaction charges.
    • Ineligibility: If any course in the bundle or individual course has been accessed or started, no refund will be issued, even within the 7-day window.
    • Course Expiry & Access: All purchased courses and bundles are accessible for the duration mentioned at the time of purchase. Unused access or non-completion does not qualify for a refund outside the eligible window.


    To request a refund, please email support@emedevents.com with your order details and reason for cancellation.

    Scan to download eMedEvents app

    Download eMedEvents Mobile App

    Track your CE certificates and CME requirements anytime, anywhere.

    Download on App StoreGet it on Google Play
    Quick Linksfooter

    Copyrights © 2026 eMedEvents Corporation, All Rights Reserved